Befejeződött1. fázis
Study to assess the safety and tolerability of CMR316 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis.
Key facts
- Where
- Hanover, NémetországSee the site
- Phase
- 1. fázis
Where in Németország
- The Fraunhofer Institute For Toxicology And Experimental Medicine ITEMHanover, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Scripps Research Institute
- Trial code
- EU 2023-510456-23-00
- Record updated
- 2026. május 8.